INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,606 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
CH
Connelly Elizabeth H.See Remarks
CDWCDW Corp
Tax withholding
F$52K
363 sh
Nov 24, 2025Nov 26, 2025
Page 1731 of 1841
← PrevNext →
traded Nov 24, 2025
+2d
SEC Form 4

Evidence

12
MR
Meade Tyler RobertsChief Legal Officer
GEMIGemini Space Station, Inc.
Tax withholding
F$146K
13.6K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

12
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Gift
G—
7,225 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

12
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Gift
G—
7,225 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

12
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Gift
G—
300.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

12
HE
Hays Von ESr EVP and Chief Legal Officer
CMACOMERICA INC
Option exercise
M$87K
1,220 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

12
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Gift
G—
300.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

12
KG
Kao GeorgeSVP, OPERATIONS
SMCISuper Micro Computer, Inc.
Option exercise
M$200K
8,154 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

12
WS
Weiskircher StevenSVP & Chief Technology Officer
LQDTLIQUIDITY SERVICES INC
Option exercise
M$51K
2,321 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

12
KR
Kenison Michael R.Chief Operations Officer
PRLBProto Labs Inc
Open-market sale · 10b5-1 plan
SELL$153K
3,048 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

12
BE
Beard Marshall EdmundDirector, Chief Operating Officer
GEMIGemini Space Station, Inc.
Tax withholding
F$208K
19.3K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Nov 21, 2025Nov 26, 2025
traded Nov 21, 2025
+5dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
6,700 sh
Nov 26, 2025Nov 26, 2025
traded Nov 26, 2025
+0dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
5,400 sh
Nov 26, 2025Nov 26, 2025
traded Nov 26, 2025
+0dSEC Form 4

Evidence

11
KR
Kenison Michael R.Chief Operations Officer
PRLBProto Labs Inc
Option exercise · 10b5-1 plan
M—
3,048 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

11
QF
Qureshi FawwadChief Financial Officer
TRUPTRUPANION, INC.
Option exercise · 10b5-1 plan
M—
3,750 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

11
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
5,000 sh
Nov 22, 2025Nov 26, 2025
traded Nov 22, 2025
+4dSEC Form 4

Evidence

11
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$24K
624 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

10
PA
Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr
SIBNSI-BONE, Inc.
Open-market sale · 10b5-1 plan
SELL$8,000
400 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

10
QF
Qureshi FawwadChief Financial Officer
TRUPTRUPANION, INC.
Tax withholding · 10b5-1 plan
F$52K
1,475 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weiskircher StevenSVP & Chief Technology Officer
LQDTLIQUIDITY SERVICES INC
Option exercise
M$16K
946 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
PL
Patterson Kathleen L.Chief HR & Corp Citizenship
ALLYAlly Financial Inc.
Tax withholding
F$18K
469 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
TR
Trout Harry R. IIISee Remarks
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
12.9K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Option exercise
M—
452 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
KL
Kieffer Tara LynnChief Product Strategy Officer
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
100.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
LR
Luly Jay R.Director, President and CEO
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
310.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Wheeler SimonEVP, Trupanion International
TRUPTRUPANION, INC.
Tax withholding
F$5,304
150 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
MT
McGrath Austin ThomasVP, CAO, and Controller
ALLYAlly Financial Inc.
Tax withholding
F$979
26 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
MT
McGrath Austin ThomasVP, CAO, and Controller
ALLYAlly Financial Inc.
Tax withholding
F$1,995
53 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
AK
Allanson KatherineChief Financial Officer
VHCVirnetX Holding Corp
Grant or award
A—
30.0K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Tax withholding
F$318
9 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
MT
McGrath Austin ThomasVP, CAO, and Controller
ALLYAlly Financial Inc.
Tax withholding
F$1,544
41 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Option exercise
M—
734 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Wheeler SimonEVP, Trupanion International
TRUPTRUPANION, INC.
Option exercise
M—
975 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
GA
Gorman AndrewGeneral Counsel&Corp Secretary
BRCBRADY CORP
Option exercise
M—
6,059 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Option exercise
M—
354 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Option exercise
M—
40 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
DA
Davis Seth AnthonyVICE PRESIDENT, CONTROLLER
RLIRLI CORP
Option exercise
M—
11.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence

9
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Tax withholding
F$301
723 sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC Form 4

Evidence

9
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Option exercise
M—
29 sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC Form 4

Evidence